The medical devices sector is typified by frequent change and innovation, in response to problems and issues faced by the healthcare industry. As a result, the sector has seen the emergence of several start-up medtech companies offering disruptive, cutting-edge solutions. Most of these are private companies, where data such as revenue is frequently not disclosed. National estimates for CardioCommand sales in the US from 2017 to 2023, as well as year-on-year growth rates, can be viewed in GlobalData’s micro revenue report. Buy the report here.

Smarter leaders trust GlobalData

Report-cover

Data Insights CardioCommand Inc, United States Revenue

Buy the Report

Data Insights

The gold standard of business intelligence.

Find out more

CardioCommand Inc (CardioCommand) is a medical device company that develops patient monitoring devices. The company’s products include model 7a stimulator, model 3 preamplifier, tapcath 205, tapcath model 1600, tapscope 210, tapscope 210-s with stylet, instrument cable, patient lead wire, ep connect cable model 8032, octapolar, interface cable, ep connect cable, tapsystem model 2a, tapscope 550 male temp. connector, tapscope 550f female temp. connector, ec-view. patient cable, pole mount, among others. It markets its products under TAPSYSTEM and statMAP brands. CardioCommand is headquartered in Tampa, Florida, the US.

The key metrics of CardioCommand related to marketed and pipeline products, ongoing clinical trials, active jobs and publications from 2023 are shown below:

As CardioCommand is a privately held company, it is not required to disclose its financial information and there is no stock listed on an exchange. GlobalData has access to a proprietary data set containing invoice data from over 2,600 healthcare institutions in the US and is therefore able to use estimations of a company’s revenue and growth to value private companies such as CardioCommand.

For a detailed understanding of the performance of CardioCommand, buy the report here.

Data Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article. 

GlobalData’s revenue report leverages GlobalData’s SKU tracker, which contains real-world, purchasing data from the US healthcare institutions.